Latest Insights on MAT
Micron’s Unbearable Earnings, Pay-To-Play FDA & Peloton Needs Dick’s September 30, 2022 Great Stuff
Friday Four Play: The “Bearish Exhaustion?” Edition Great Ones, I don’t like to give y’all false hope, but Micron Technology (Nasdaq: ) just continued a trend I’ve noticed building on Wall Street lately. That trend? A company issues pretty bad news, but the stock rallies anyway. In the sentiment analysis business, we call this an […]
The Biggest Volatility Myth? September 30, 2022 Investing, Investment Opportunities, Real Talk, Stocks
This is the price you pay for high returns. 
A Global Currency Reset Is Upon Us September 30, 2022 Investing, Trading Strategies, True Options Masters
Amber and I put together a few charts we think are important. So important, in fact, that they’re likely the precursor of a global monetary reset on the scale of the 2008 financial crisis…
Apple’s Appealing Advantage, Not So RAD & Beyond’s Crazy September 29, 2022 Great Stuff
These Apples Are Delicious? As a matter of fact, they are, Great Ones. Can all this fruit be free? Unfortunately, no. Apple (Nasdaq: ) is not free. But AAPL stock is down about 20% so far this year, so we’ve got that going for us … which is nice? Well, for bargain hunters at least. […]
Biogen’s Alzheimer’s All-Timer, Thor Thunders On, Cowardly Lionsgate September 28, 2022 Great Stuff
Biogen’s Redemption Song Great Ones, so this ain’t the end, I saw Biogen (Nasdaq: ). Today, I had to turn my heart away. The news smelled like the sun, BIIB for everyone. And tales … it never fails. I’ve been lying so low in the weeds that Biogen’s latest Alzheimer’s drug ambushed me. It’s got […]MEET OUR EXPERTS
Editor of Strategic Fortunes and three elite services
Editor of Alpha Investor
Research Analyst
Chief Investment Strategist of Money & Markets
Director of VIP Services
